Invention Grant
- Patent Title: Synthetic path to pharmaceutically acceptable Vismodegib
-
Application No.: US15935558Application Date: 2018-03-26
-
Publication No.: US10343998B2Publication Date: 2019-07-09
- Inventor: Christian Manfred Frech , Pasquale Gabriele Grieco , Christine Aebersold , Patrick Müller , Jan-Erik Ingenhoff , Miriam Oberholzer , Viktorya Rstakyan , Roman Gerber Aeschbacher
- Applicant: AZAD PHARMACEUTICAL INGREDIENTS AG
- Applicant Address: CH Schaffhausen
- Assignee: AZAD PHARMACEUTICAL INGREDIENTS AG
- Current Assignee: AZAD PHARMACEUTICAL INGREDIENTS AG
- Current Assignee Address: CH Schaffhausen
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: GB1704801.8 20170327
- Main IPC: C07D213/40
- IPC: C07D213/40 ; C07D213/56
Abstract:
The present invention relates to a new route of synthesis to obtain pharmaceutically acceptable Vismodegib. In addition, besides the synthesis also suitable pharmaceutical compositions and the use of the compound for the treatment of basal-cell carcinomas are disclosed.
Public/Granted literature
- US20180273477A1 Synthetic Path To Pharmaceutically Acceptable Vismodegib Public/Granted day:2018-09-27
Information query
